文献速递甲状腺与颈部外科

血钙正常型甲状旁腺功能亢进:区分原发性与继发性甲状旁腺功能亢进的干预措施

Normocalcemic hyperparathyroidism: Intervention to differentiate primary from secondary hyperparathyroidism.
PubMed 文献 · Surgery · 2023-11-18

本研究对转诊拟行甲状旁腺切除术的血钙正常(血清钙<10 mg/dL)且甲状旁腺激素升高的连续患者,前瞻性给予钙和维生素D3补充并复查实验室指标。结果显示55%患者甲状旁腺激素恢复正常而血钙持续正常,证实为继发性甲状旁腺功能亢进,避免了不必要的手术;19%患者诊断为经典原发性甲状旁腺功能亢进并接受了手术。

要点

  • 血钙正常型甲状旁腺激素升高患者中,短期补钙可揭示约50%为钙摄入不足所致继发性甲状旁腺功能亢进。
  • 术前钙负荷试验前瞻性实施依从性高(92%),可避免不必要甲状旁腺切除术。
  • 约20%患者经钙负荷试验后确诊为经典原发性甲状旁腺功能亢进,可及时正确手术。

核心结论

  • 术前钙负荷试验在血钙正常伴甲状旁腺激素升高的患者中前瞻性启动,依从性高(92%)。
  • 短期补钙显示约50%患者因钙摄入不足导致的继发性甲状旁腺功能亢进缓解,避免了不必要手术。
  • 约20%患者确诊为经典原发性甲状旁腺功能亢进,得以进行及时正确的手术干预。

研究设计与样本

  • 常规给予钙和维生素D3补充,并评估随访实验室检查。
  • 共29/314(9%)患者存在血钙正常型甲状旁腺激素升高,平均钙9.5 ± 0.3 mg/dL、甲状旁腺激素109.9 ± 34.9 pg/mL、维生素D 25OH 42.7 ± 23.8 ng/mL。

主要发现

  • 混杂因素包括估算肾小球滤过率<60者2例、使用袢利尿剂者4例、既往胃旁路或胃袖状切除术者4例。
  • 27例(92%)有随访生化评估;7例(26%)结果无变化;15例(55%)甲状旁腺激素水平恢复正常且血钙持续正常,证实为继发性甲状旁腺功能亢进。
  • 5例(19%)诊断为高钙血症伴甲状旁腺激素升高(经典原发性甲状旁腺功能亢进)。
  • 5例经典原发性甲状旁腺功能亢进患者中,迄今已完成3例甲状旁腺探查。

临床怎么用

  • 对血钙正常伴甲状旁腺激素升高的患者,可考虑术前钙负荷试验以区分原发性与继发性甲状旁腺功能亢进。
  • 短期补钙后甲状旁腺激素恢复正常且血钙持续正常者,提示继发性甲状旁腺功能亢进,可避免不必要手术。
  • 补钙后仍为高钙血症伴甲状旁腺激素升高者,提示经典原发性甲状旁腺功能亢进,可及时行手术干预。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Normocalcemic hyperparathyroidism can occur, but surgery should not be considered until common etiologies for secondary hyperparathyroidism are comprehensively excluded. Calcium deficiency is an underrecognized cause of normocalcemic parathyroid hormone elevation, and we aim to determine if the implementation of a preoperative calcium challenge can be used to reduce unnecessary parathyroidectomy. METHODS: Consecutive patients referred for parathyroidectomy (1/21-6/22) with normocalcemia (serum calcium <10 mg/dL) and concurrently elevated parathyroid hormone levels were routinely treated with supplemental calcium and vitamin D3, and follow-up laboratory studies were assessed. RESULTS: A total of 29/314 (9%) patients had normocalcemic parathyroid hormone elevation with mean calcium, parathyroid hormone, and vitamin D 25OH levels of 9.5 ± 0.3 mg/dL, 109.9 ± 34.9 pg/mL, and 42.7 ± 23.8 ng/mL respectively. Confounding factors included estimated glomerular filtration rate <60 in 2, loop diuretic use in 4, and prior gastric bypass or gastric sleeve surgery in 4. Follow-up biochemical evaluation was available in 27 (92%); results were unchanged in 7 patients (26%); normalization of parathyroid hormone levels with persistently normal calcium levels occurred in 15 (55%), thus confirming secondary hyperparathyroidism and hypercalcemia with elevated parathyroid hormone levels (classic primary hyperparathyroidism) was diagnosed in 5 (19%). Parathyroid exploration has been completed for 3 of 5 patients with classic primary hyperparathyroidism to date. CONCLUSION: A preoperative calcium challenge was prospectively initiated in normocalcemic patients with parathyroid hormone elevation, and there was high compliance (92%). Short-interval calcium supplementation revealed ∼50% to have resolved secondary hyperparathyroidism due to insufficient calcium intake, which avoided unnecessary surgery. In contrast, classic patients were unveiled in 20%, allowing for prompt and correct surgical intervention.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Baugh KA, McCoy KL, Leung JH, et al. Normocalcemic hyperparathyroidism: Intervention to differentiate primary from secondary hyperparathyroidism. Surgery. 2023. PMID: 37981554. doi:10.1016/j.surg.2023.06.056

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。